Are meta analysis methods valid — Reverse meta analysis
- 作者Sebastian T. Palmeri; John B. Kostis; Ron Cody; Alan C. Wilson; Daniel M. Shindler; William Strawderman
- 卷第27卷
- 文件大小175.95KB
- 发表时间1996
- DOI10.1016/s0735-1097(96)80559-6
Effect of gender on prognosis in patients with myocardial infarction and type 2 diabetesL. Venskutonyte; K. Malmberg; A. Norhammar; H. Wedel; L. Rydén · 2010
Insulin-induced weight gain and cardiovascular events in patients with type 2 diabetes. A report from the DIGAMI 2 studyA.-M. Aas; J. Öhrvik; K. Malmberg; L. Rydén; K. I. Birkeland; the DIGAMI 2 Investigators · 2009
Intense Metabolic Control by Means of Insulin in Patients With Diabetes Mellitus and Acute Myocardial Infarction (DIGAMI 2): Effects on Mortality and MorbidityK. Malmberg; L. Rydén; H. Wedel · 2005
Abnormal glucose tolerance – a common risk factor in patients with acute myocardial infarction in comparison with population-based controlsM. Bartnik; K. Malmberg; A. Hamsten; S. Efendic; A. Norhammar; A. Silveira; Å. Tenerz; J. Öhrvik; L. Rydén · 2004
Beta cell dysfunction in patients with acute myocardial infarction but without previously known type 2 diabetes: a report from the GAMI studyM. Wallander; M. Bartnik; S. Efendic; A. Hamsten; K. Malmberg; J. Öhrvik; L. Rydén; A. Silveira; A. Norhammar · 2005
Prognostic implications of glucose-lowering treatment in patients with acute myocardial infarction and diabetes: experiences from an extended follow-up of the Diabetes Mellitus Insulin–Glucose Infusion in Acute Myocardial Infarction (DIGAMI) 2 StudyL. G. Mellbin; K. Malmberg; A. Norhammar; H. Wedel; L. Rydén; for the DIGAMI 2 Investigators · 2011